Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
VP, Pharmaceutical Development
-
Stock Symbol
-
GNLX on Nasdaq
Joseph Cappello - trading volume in the past year for GENELUX Corp
Holdings reported by Joseph Cappello for GENELUX Corp
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
43.7K |
$102K |
$2.34 |
Dec 18, 2024 |
Direct |
|
|
| Stock Option (right to buy) |
39K |
|
|
Dec 18, 2024 |
Direct |
Common Stock |
|
Transactions reported by Joseph Cappello for GENELUX Corp
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.